000			02251 a2200637 4500
005			20250516144900.0
264		0	_c20131031
008			201310s 0 0 eng d
022			_a1558-3597
024	7		_a10.1016/j.jacc.2013.03.037 _2doi
040			_aNLM _beng _cNLM
100	1		_aGurbel, Paul A
245	0	0	_aThe influence of smoking status on the pharmacokinetics and pharmacodynamics of clopidogrel and prasugrel: the PARADOX study. _h[electronic resource]
260			_bJournal of the American College of Cardiology _cAug 2013
300			_a505-12 p. _bdigital
500			_aPublication Type: Journal Article; Multicenter Study; Randomized Controlled Trial
650	0	4	_aAged
650	0	4	_aAryl Hydrocarbon Hydroxylases _xgenetics
650	0	4	_aAspirin _xtherapeutic use
650	0	4	_aClopidogrel
650	0	4	_aCoronary Artery Disease _xdrug therapy
650	0	4	_aCross-Over Studies
650	0	4	_aCytochrome P-450 CYP1A2 _xmetabolism
650	0	4	_aCytochrome P-450 CYP2C19
650	0	4	_aDouble-Blind Method
650	0	4	_aDrug Therapy, Combination
650	0	4	_aFemale
650	0	4	_aHumans
650	0	4	_aMale
650	0	4	_aMiddle Aged
650	0	4	_aPiperazines _xpharmacokinetics
650	0	4	_aPlatelet Aggregation Inhibitors _xpharmacokinetics
650	0	4	_aPlatelet Function Tests
650	0	4	_aPrasugrel Hydrochloride
650	0	4	_aProspective Studies
650	0	4	_aPurinergic P2Y Receptor Antagonists _xpharmacokinetics
650	0	4	_aSmoking _xmetabolism
650	0	4	_aThiophenes _xpharmacokinetics
650	0	4	_aTiclopidine _xanalogs & derivatives
700	1		_aBliden, Kevin P
700	1		_aLogan, Douglas K
700	1		_aKereiakes, Dean J
700	1		_aLasseter, Kenneth C
700	1		_aWhite, Alex
700	1		_aAngiolillo, Dominick J
700	1		_aNolin, Thomas D
700	1		_aMaa, Jen-Fue
700	1		_aBailey, William L
700	1		_aJakubowski, Joseph A
700	1		_aOjeh, Clement K
700	1		_aJeong, Young-Hoon
700	1		_aTantry, Udaya S
700	1		_aBaker, Brian A
773	0		_tJournal of the American College of Cardiology _gvol. 62 _gno. 6 _gp. 505-12
856	4	0	_uhttps://doi.org/10.1016/j.jacc.2013.03.037 _zAvailable from publisher's website
999			_c22685437 _d22685437